A $1 million grant will help Children’s Hospital of Philadelphia test a new approach to treating an especially deadly form of brain cancer.
CHOP is planning a clinical trial for diffuse midline glioma, an aggressive childhood cancer with few treatment options.
Researchers will look at a new form of CAR T-cell therapy using mRNA technology. CHOP says the approach has shown promise in early lab testing.
The money comes from the Children’s Cancer Research Fund.
(Photo credit: CHOP)




